Yiwen Luo

Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study

Charles M. Rudin, Mark M. Awad, Alejandro Navarro et al. · Journal of Clinical Oncology · 2020 · 729 citations · Full text

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

James Chih‐Hsin Yang, Dae Ho Lee, Jong‐Seok Lee et al. · Journal of Clinical Oncology · 2024 · 123 citations · Full text

Pemetrexed and platinum with or without pembrolizumab for tyrosine kinase inhibitor (TKI)-resistant, <i>EGFR</i> -mutant, metastatic nonsquamous NSCLC: Phase 3 KEYNOTE-789 study.

James Chih‐Hsin Yang, Dae Ho Lee, Jong Seok Lee et al. · Journal of Clinical Oncology · 2023 · 92 citations

Maternal blood cadmium, lead and arsenic levels, nutrient combinations, and offspring birthweight

Yiwen Luo, Lauren E. McCullough, Jung‐Ying Tzeng et al. · BMC Public Health · 2017 · 91 citations · Full text

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial

Quincy S. Chu, Laurent Greillier, Wei Tu et al. · The Lancet · 2023 · 86 citations

Chemotherapy Versus Chemotherapy, Oncology, Pathology +5